JP2018523483A5 - - Google Patents

Download PDF

Info

Publication number
JP2018523483A5
JP2018523483A5 JP2018509494A JP2018509494A JP2018523483A5 JP 2018523483 A5 JP2018523483 A5 JP 2018523483A5 JP 2018509494 A JP2018509494 A JP 2018509494A JP 2018509494 A JP2018509494 A JP 2018509494A JP 2018523483 A5 JP2018523483 A5 JP 2018523483A5
Authority
JP
Japan
Prior art keywords
polypeptide
medicament
fusion polypeptide
amino acid
medicament according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018509494A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018523483A (ja
JP6859320B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/069680 external-priority patent/WO2017029389A1/en
Publication of JP2018523483A publication Critical patent/JP2018523483A/ja
Publication of JP2018523483A5 publication Critical patent/JP2018523483A5/ja
Application granted granted Critical
Publication of JP6859320B2 publication Critical patent/JP6859320B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018509494A 2015-08-20 2016-08-19 臓器不全の治療および予防用のb7−h1融合ポリペプチド Active JP6859320B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15181800.2 2015-08-20
EP15181800 2015-08-20
PCT/EP2016/069680 WO2017029389A1 (en) 2015-08-20 2016-08-19 B7-h1 fusion polypeptides for treating and preventing organ failure

Publications (3)

Publication Number Publication Date
JP2018523483A JP2018523483A (ja) 2018-08-23
JP2018523483A5 true JP2018523483A5 (OSRAM) 2019-09-26
JP6859320B2 JP6859320B2 (ja) 2021-04-14

Family

ID=54014503

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018509494A Active JP6859320B2 (ja) 2015-08-20 2016-08-19 臓器不全の治療および予防用のb7−h1融合ポリペプチド

Country Status (7)

Country Link
US (2) US10632174B2 (OSRAM)
EP (1) EP3337496B1 (OSRAM)
JP (1) JP6859320B2 (OSRAM)
CN (2) CN107921093B (OSRAM)
CA (1) CA2995987C (OSRAM)
ES (1) ES2851474T3 (OSRAM)
WO (1) WO2017029389A1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS61943B1 (sr) 2015-04-17 2021-07-30 Alpine Immune Sciences Inc Imunomodulatorni proteini sa prilagodljivim afinitetima
IL310729A (en) 2016-04-15 2024-04-01 Alpine Immune Sciences Inc Immunomodulatory proteins that are variants of CD80 and their uses
EP3491013A1 (en) 2016-07-28 2019-06-05 Alpine Immune Sciences, Inc. Cd155 variant immunomodulatory proteins and uses thereof
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
WO2018022945A1 (en) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Cd112 variant immunomodulatory proteins and uses thereof
JP2020511144A (ja) 2017-03-16 2020-04-16 アルパイン イミューン サイエンシズ インコーポレイテッド Pd−l2バリアント免疫調節タンパク質及びその使用
IL320149A (en) * 2017-03-16 2025-06-01 Alpine Immune Sciences Inc Pd-l1 variant immunomodulatory proteins and uses thereof
EP3596114A2 (en) 2017-03-16 2020-01-22 Alpine Immune Sciences, Inc. Cd80 variant immunomodulatory proteins and uses thereof
WO2019136179A1 (en) 2018-01-03 2019-07-11 Alpine Immune Sciences, Inc. Multi-domain immunomodulatory proteins and methods of use thereof
JP7713886B2 (ja) 2018-11-30 2025-07-28 アルパイン イミューン サイエンシズ インコーポレイテッド Cd86バリアント免疫調節タンパク質およびその使用
US10650210B1 (en) 2019-03-18 2020-05-12 Haier Us Appliance Solutions, Inc. Method for authenticating a filter cartridge for a refrigerator appliance
CN115605505A (zh) * 2020-04-30 2023-01-13 弗劳恩霍夫应用研究促进协会(De) 对pd-1亲和力增强的pd-l1变体
WO2021231376A2 (en) 2020-05-12 2021-11-18 Cue Biopharma, Inc. Multimeric t-cell modulatory polypeptides and methods of use thereof
EP4211149A4 (en) * 2020-09-09 2024-10-09 Cue Biopharma, Inc. MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
WO2022245841A1 (en) * 2021-05-17 2022-11-24 Wisconsin Alumni Research Foundation Synthetic protein for inducing immune tolerance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9657082B2 (en) * 2013-01-31 2017-05-23 Thomas Jefferson University PD-L1 and PD-L2-based fusion proteins and uses thereof
EP3470081A1 (en) 2013-10-01 2019-04-17 Mayo Foundation for Medical Education and Research Methods for treating cancer in patients with elevated levels of bim

Similar Documents

Publication Publication Date Title
JP2018029594A5 (OSRAM)
Farrar et al. The innate immune system and transplantation
JP2017515460A5 (OSRAM)
JP2018512856A5 (OSRAM)
EP4282430A3 (en) Garp-tgf-beta antibodies
JP2014530253A5 (OSRAM)
JP2016529229A5 (OSRAM)
JP2020533273A5 (OSRAM)
Kroger et al. Therapies to suppress β cell autoimmunity in type 1 diabetes
JP2016527286A5 (OSRAM)
JP2014508748A5 (OSRAM)
JP2017538401A5 (OSRAM)
JP2020501550A5 (OSRAM)
JP2019519215A5 (OSRAM)
JP2013506411A5 (OSRAM)
HK1210792A1 (en) Molecules with antigen binding and polyvalent fc gamma receptor binding activity
JP2018509936A5 (OSRAM)
FI3421486T3 (fi) Uusia vista-ig-rakenteita ja vista-ig:n käyttö autoimmuuni-, allergia- ja tulehdushäiriöiden hoitamiseksi
JP2018509163A5 (OSRAM)
AU2014307725A1 (en) T cell receptors
JP2018520679A5 (OSRAM)
JP2018508219A5 (OSRAM)
JP2014110810A5 (OSRAM)
JP2016527314A5 (OSRAM)
JP2018510132A5 (OSRAM)